RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jan. 10, 2006--Oriel Therapeutics, an inhaled drug delivery company based in Research Triangle Park, announced today that an extension of its novel powder fluidization technology has been granted a United States Patent (No. US 6,985,798 issue date Jan. 10th, 2006) for dry powder dose filling systems and methods. The patent covers vibratory fluidization of powders for high precision metering of poorly flowing powders into premeasured doses such as required by inhaler products. The technology is an extension of Oriel's existing intellectual property on powder fluidization control for active dry powder inhaler systems. The powder metering technology can reduce the time required to formulate powder drug products for transfer from R&D to manufacturing. Applications in other industries are also being explored.
